Showing results (251-260 of 288) with videos related to
Sort By:
Pageof 29
Cells|August 12, 2022
β-Glucocerebrosidase Deficiency Activates an Aberrant Lysosome-Plasma Membrane Axis Responsible for the Onset of NeurodegenerationGiulia Lunghi, Emma Veronica Carsana, Nicoletta Loberto, et al.Journal of the American College of Cardiology|January 7, 2012
Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk StudyPatrick L Whitlow, Ted Feldman, Wes R Pedersen, et al.Circulation. Cardiovascular Interventions|November 11, 2010
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesionsJohn A Ormiston, Alexandre Abizaid, John Spertus, et al.Journal of the American Society of Hypertension : JASH|September 13, 2015
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trialJohn M Flack, Deepak L Bhatt, David E Kandzari, et al.Journal of the American College of Cardiology|December 19, 2006
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trialDavid E Kandzari, Martin B Leon, Jeffrey J Popma, et al.Circulation|March 20, 2016
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy StudyIan T Meredith, Jean-François Tanguay, Dean J Kereiakes, et al.Scientific Reports|December 20, 2019
Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1+/- mouse modelElena Chiricozzi, Laura Mauri, Giulia Lunghi, et al.JAMA|March 30, 2016
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary InterventionRobert W Yeh, Eric A Secemsky, Dean J Kereiakes, et al.The New England Journal of Medicine|April 6, 2011
Percutaneous repair or surgery for mitral regurgitationTed Feldman, Elyse Foster, Donald D Glower, et al.Journal of the American College of Cardiology|April 3, 2012
Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trialHoward C Herrmann, Zachary M Gertz, Frank E Silvestry, et al.Pageof 29